This activity is intended for internal CCAD Physicians

Activity Description:

This activity will discuss their disease diagnosis, disease progression, pathophysiology, and treatment. At the same time review their liver transplant candidacy after extensive workup. This activity will also review patients with liver tumors and assess their treatment options prior to placing on the waiting list for liver transplantation.

Target Audience: 

Liver Transplant, Hepatology and HPB surgery

Learning Objectives:

Participants will be able to achieve the below:

• M&M review
• Review and identify patient selection and listing
• Discuss post transplant care of complex cases and engage in safety outcomes and quality care
• Discuss protocols and literature updates

Faculty Disclosure:

In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), Cleveland Clinic Abu Dhabi for Continuing Education mitigates all faculty conflicts of interest to ensure CME activities are free of commercial bias.

Activity Director(s): Lius Campo, MD

The planning committee, faculty, and others in control of content (either individually or as a group) have NO relevant financial relationship(s) to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation Statement:

Cleveland Clinic Abu Dhabi for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for to provide continuing education for the healthcare team.

Credit Designation:

This activity was designated for 1.00 AMA PRA Category 1^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.